Nutex Health (NUTX) Reports Mixed Earnings, Is A 32% Discount Still Justified?

Nutex Health (NUTX) drew fresh attention on 5 November 2026 after reporting third quarter results that paired softer revenue and earnings with sharply higher net income over the first nine months.

Nutex Health’s latest earnings update landed alongside a sharp pullback in the shares, with the price down 5.64% on the day and 11.34% over 30 days. However, the 90 day share price return of 19.48% and one year total shareholder return of 59.06% show that longer term momentum remains strong.

Scan for other healthcare stocks showing a similar mix of pressure on recent earnings and stronger multi quarter trends by checking the curated 34 healthcare AI stocks.

Nutex Health now pairs a strong multi quarter share price run with a fresh pullback after mixed quarterly numbers. Is most of the easy upside already behind the stock, or does the current valuation still leave room ahead?

Most Popular Narrative: 32% Undervalued

The most followed narrative pins Nutex Health’s fair value at $283, compared with the latest close at $193.64, which frames the recent pullback against a still sizable implied upside gap.

Strong population growth and an aging demographic are increasing demand for healthcare services, resulting in double-digit growth in patient visits (+15.5% YoY for first half 2025) and robust pipeline expansion. This trend is expected to continue to drive top-line revenue growth as new micro-hospitals open in high-demand markets. The continued shift toward consumer-driven and ambulatory care is expanding Nutex Health's addressable market, with their micro-hospital and freestanding ER model aligning with preferences for convenient, efficient care. This supports enhanced market share and greater revenue per visit over time.

See why 21 investors see Nutex Health as 32% undervalued.

Result: Fair Value of $283 (UNDERVALUED)

Still, the story around Nutex Health can change quickly if arbitration-driven revenue weakens or if regulatory shifts reduce reimbursement clarity and cash collection.

Find out about the key risks to this Nutex Health narrative.

Next Steps

Mixed signals around Nutex Health often create as many questions as answers, so use that uncertainty as a prompt to act promptly and form your own view by weighing its 4 key rewards and 3 important warning signs.

Looking for more Nutex Health style investment ideas?

If Nutex Health has your attention, do not stop here. Use the same tools to hunt for fresh opportunities before others get curious.

• Target potential upside by scanning a 21 high quality undiscovered gems that could still be flying under the radar while the market looks elsewhere.
• Prioritise resilience by sorting through a 32 resilient stocks with low risk scores so you can focus on businesses with sturdier financial risk profiles.
• Strengthen portfolio quality by filtering companies through a list of solid balance sheet and fundamentals (24 results) and keep your capital working in financially sound operations.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com